Smith L. Mary
- SEC CIK
- 0001787013
No open-market purchases or sales filed in the past year.
Current role at each company
- SWTX SpringWorks Therapeutics, Inc.Chief Development Officeras of Jan 8, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Smith L. Mary as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 13, 2021 (view filing) | Oct 13 | Same day | Smith L. MaryChief Development Officer | SSale | −10.0K | $55.97 | −$559.7K | −5.6%167.5K after | |
| Jul 14, 2021 (view filing) | Jul 13 | 1 day | Smith L. MaryChief Development Officer | SSale | −10.0K | $80.88 | −$808.8K | −5.6%167.5K after |